Downstream Gene Activation of the Receptor ALX by the Agonist Annexin A1
Open Access
- 17 September 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9) , e12771
Abstract
Our understanding of pro-resolution factors in determining the outcome of inflammation has recently gained ground, yet not many studies have investigated whether specific genes or patterns of genes, are modified by these mediators. Here, we have focussed on the glucocorticoid modulated pro-resolution factor annexin A1 (AnxA1), studying if its interaction with the ALX receptor would affect downstream genomic targets. Using microarray technology in ALX transfected HEK293 cells, we discovered an over-lapping, yet distinct gene activation profile for AnxA1 compared to its N-terminal mimetic peptide Ac2-26, which may be suggestive of unique downstream inflammatory outcomes for each substance. When the up-regulated genes were explored, consistently induced was the sphingosine phosphate phosphatase-2 gene (SGPP2), involved in regulation of the sphingosine 1 phosphate chemotactic system. Up-regulation of this gene, as well as JAG1 (and down-regulation of JAM3), was confirmed using real time PCR both with transfected HEK293 cells and human peripheral blood leukocytes. Furthermore, lymph nodes taken from AnxA1null mice displayed lower SGPP2 gene activity. Finally, connectivity map analysis for AnxA1 and peptide Ac2-26 indicated striking similarities with known anti-inflammatory therapeutics, glucocorticoids and aspirin-like compounds, as well as with histone deacetylase inhibitors. We believe these new data raise the profile of AnxA1 from being solely a short-term anti-inflammatory factor, to being a ‘trigger’ of the endogenous pro-resolution arsenal.Keywords
This publication has 47 references indexed in Scilit:
- On the adaptive nature of Annexin-A1Current Opinion in Pharmacology, 2009
- International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) FamilyPharmacological Reviews, 2009
- Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synoviumArthritis & Rheumatism, 2008
- Annexin‐A1: a pivotal regulator of the innate and adaptive immune systemsBritish Journal of Pharmacology, 2008
- HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsBrain Research, 2008
- Getting to the site of inflammation: the leukocyte adhesion cascade updatedNature Reviews Immunology, 2007
- Expression and function of junctional adhesion molecule-C in human and experimental arthritisArthritis Research & Therapy, 2007
- Resolution of in flammation: state of the art, definitions and termsThe FASEB Journal, 2007
- Annexin-1 modulates T-cell activation and differentiationBlood, 2006
- Aberrant inflammation and resistance to glucocorticoids in Annexin 1 −/− MouseThe FASEB Journal, 2002